MX2012008798A - Sintesis de derivados de pirazolin carboxamidina sustituida. - Google Patents

Sintesis de derivados de pirazolin carboxamidina sustituida.

Info

Publication number
MX2012008798A
MX2012008798A MX2012008798A MX2012008798A MX2012008798A MX 2012008798 A MX2012008798 A MX 2012008798A MX 2012008798 A MX2012008798 A MX 2012008798A MX 2012008798 A MX2012008798 A MX 2012008798A MX 2012008798 A MX2012008798 A MX 2012008798A
Authority
MX
Mexico
Prior art keywords
synthesis
carboxamidine derivatives
substituted pyrazoline
pyrazoline carboxamidine
derivatives
Prior art date
Application number
MX2012008798A
Other languages
English (en)
Inventor
Josephus H M Lange
Gerrit A Barf
Arnold Van Loevezijn
Hartog Arnold P Den
Original Assignee
Abbott Healthcare Products Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv
Publication of MX2012008798A publication Critical patent/MX2012008798A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Esta invención se relaciona con química orgánica; en particular, con procedimientos para la preparación de derivados de pirazolin carboxamidina de fórmula (I), conocidos como potentes antagonistas de 5-HT6 la invención también se relaciona con los intermediarios novedosos de estos compuestos, en donde los símbolos tienen los significados dados en la descripción (Ver Formula).
MX2012008798A 2010-01-29 2011-01-27 Sintesis de derivados de pirazolin carboxamidina sustituida. MX2012008798A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29936310P 2010-01-29 2010-01-29
EP10152097 2010-01-29
PCT/EP2011/051100 WO2011092226A1 (en) 2010-01-29 2011-01-27 Synthesis of substituted pyrazoline carboxamidine derivatives

Publications (1)

Publication Number Publication Date
MX2012008798A true MX2012008798A (es) 2012-08-17

Family

ID=42244995

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008798A MX2012008798A (es) 2010-01-29 2011-01-27 Sintesis de derivados de pirazolin carboxamidina sustituida.

Country Status (22)

Country Link
US (1) US9422244B2 (es)
EP (1) EP2528900B1 (es)
JP (1) JP5792195B2 (es)
KR (1) KR20120129929A (es)
CN (1) CN102725272B (es)
AR (1) AR079935A1 (es)
AU (1) AU2011209372B2 (es)
CA (1) CA2787289A1 (es)
DK (1) DK2528900T3 (es)
ES (1) ES2485891T3 (es)
HK (1) HK1174638A1 (es)
HR (1) HRP20140655T1 (es)
MX (1) MX2012008798A (es)
PL (1) PL2528900T3 (es)
PT (1) PT2528900E (es)
RS (1) RS53498B1 (es)
RU (1) RU2550694C2 (es)
SG (1) SG182635A1 (es)
SI (1) SI2528900T1 (es)
SM (1) SMT201400119B (es)
TW (1) TWI547485B (es)
WO (1) WO2011092226A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105665148B (zh) * 2016-01-15 2018-05-04 中南大学 一种异硫氰酸酯衍生物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156007A (en) 1974-07-12 1979-05-22 U.S. Philips Corporation Pyrazoline compounds
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
JPS608211A (ja) 1983-06-28 1985-01-17 Showa Denko Kk 農園芸用殺菌剤
JPH062742B2 (ja) * 1987-06-17 1994-01-12 三井東圧化学株式会社 新規２‐ピラゾリン類及びそれを有効成分とする脳血管障害治療剤
SI1373216T1 (en) 2001-03-22 2005-06-30 Solvay Pharmaceuticals B.V. 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
KR100950430B1 (ko) * 2001-09-21 2010-04-02 솔베이 파마슈티칼스 비. 브이 효력있는 ｃｂ1-길항 작용을 가지는4,5-디하이드로-1ｈ-피라졸 유도체
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
AU2006328483A1 (en) 2005-12-20 2007-06-28 Solvay Pharmaceuticals B.V. 4,5-dihydro- (1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
TW200730500A (en) 2005-12-20 2007-08-16 Solvay Pharm Bv 4, 5-dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
TWI428334B (zh) 2006-09-22 2014-03-01 Abbvie Bahamas Ltd 作為５-ｈｔ6拮抗劑之磺醯基吡唑及磺醯基吡唑啉的甲脒衍生物
WO2009086303A2 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
AR070898A1 (es) * 2008-03-18 2010-05-12 Solvay Pharm Bv Derivados de arilsulfonil pirazolin carboxamidina como antagonistas de 5-ht6
RU2374233C1 (ru) 2008-05-19 2009-11-27 Государственное образовательное учреждение высшего профессионального образования "Российский химико-технологический университет им. Д.И. Менделеева" (РХТУ им. Д.И. Менделеева) ЗАМЕЩЕННЫЕ 2-ТИОКАРБАМОИЛ-3-ФЕНИЛ-3,3а,4,5,6,7-ГЕКСАГИДРО-2Н-ИНДАЗОЛЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ) И ФУНГИЦИДНАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ
TW201010981A (en) 2008-08-01 2010-03-16 Solvay Pharm Bv Synthesis of 3,4-diaryl-4,5-dihydro-(1H)-pyrazole-1-carboxamidine derivatives

Also Published As

Publication number Publication date
RU2550694C2 (ru) 2015-05-10
CN102725272B (zh) 2015-07-15
WO2011092226A1 (en) 2011-08-04
SG182635A1 (en) 2012-08-30
JP2013518080A (ja) 2013-05-20
JP5792195B2 (ja) 2015-10-07
HRP20140655T1 (hr) 2014-10-10
ES2485891T3 (es) 2014-08-14
DK2528900T3 (da) 2014-08-25
SMT201400119B (it) 2014-11-10
RU2012136831A (ru) 2014-03-10
PL2528900T3 (pl) 2014-10-31
AU2011209372B2 (en) 2015-06-04
AU2011209372A1 (en) 2012-08-30
US9422244B2 (en) 2016-08-23
SI2528900T1 (sl) 2014-09-30
CA2787289A1 (en) 2011-08-04
US20130060041A1 (en) 2013-03-07
CN102725272A (zh) 2012-10-10
WO2011092226A8 (en) 2012-09-07
PT2528900E (pt) 2014-08-29
TW201125852A (en) 2011-08-01
RS53498B1 (en) 2015-02-27
TWI547485B (zh) 2016-09-01
EP2528900A1 (en) 2012-12-05
KR20120129929A (ko) 2012-11-28
AR079935A1 (es) 2012-02-29
EP2528900B1 (en) 2014-06-11
HK1174638A1 (en) 2013-06-14

Similar Documents

Publication Publication Date Title
MX2011008864A (es) Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales.
MX350892B (es) Síntesis de compuesto antiviral.
AU2011232516A8 (en) Chemical compounds
PT2470546E (pt) Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor
MX2013012652A (es) Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparacion y su uso como antagonistas p2y12.
MX340572B (es) Proceso para la fabricacion de compuestos farmaceuticamente activos.
MY164776A (en) Heterocyclic compound
MY173448A (en) Phenyl and benzodioxinly substituted indazoles derivatives
MX2016007128A (es) Compuestos del receptor 6 de quimiocina (ccr6).
MX2012002997A (es) Derivados de eter de los heteroarilos biciclicos.
UA102289C2 (ru) Гербициды, полученные из циклопентадиона
EA201101675A1 (ru) Спироэпоксиды как промежуточные продукты синтеза
MX360330B (es) Regimen de administracion para nitrocatecoles.
MX360872B (es) Nuevas composiciones para la produccion de poliamidas coladas.
MX2012006524A (es) Proceso para la sintesis de compuestos intermedios de utilidad para preparar compuestos sustituidos de indazol y azaindol.
HK1124842A1 (en) Methods of preparing imidazole-based compounds
TN2011000355A1 (en) Novel microbiocides
MX2012007835A (es) Derivados de oxazolopirimidina sustituida en 2, 5,7.
EA200801549A1 (ru) Новые производные фенантридина в качестве антагонистов брадикинина
EA201170997A1 (ru) Производные индола в качестве противораковых агентов
EA201000703A1 (ru) Производные пиразола в качестве ингибиторов 5-lo
WO2014172363A3 (en) Combretastatin analogs
IN2012DN02000A (es)
IN2012DN01223A (es)
MX2012008798A (es) Sintesis de derivados de pirazolin carboxamidina sustituida.

Legal Events

Date Code Title Description
FG Grant or registration